• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

    2/13/24 4:55:58 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    SC 13G/A 1 tv0032-carlylegroupincthe.htm SCHEDULE 13G/A carlylegroupincthe

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 2)*

    Name of issuer:  Carlyle Group Inc/The

    Title of Class of Securities:  Common Stock

    CUSIP Number:  14316J108

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  14316J108

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    132,312

    7.  SOLE DISPOSITIVE POWER

    24,393,813

    8.  SHARED DISPOSITIVE POWER

    482,375

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    24,876,188

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    6.89%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Carlyle Group Inc/The

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    1001 Pennsylvania Avenue NW
    Washington, DC 20004-2505

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    14316J108

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    More analyst ratings

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:37:43 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-Q filed by The Carlyle Group Inc.

    10-Q - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:11:15 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 6,815,617 units of Class B Common Stock, sold $554,953,657 worth of shares (19,136,333 units at $29.00), disposed of 1,549,243 shares and converted options into 6,815,617 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    12/22/25 4:30:22 PM ET
    $CG
    Investment Managers
    Finance

    Chief Operating Officer Lobue Lindsay was granted 183,655 shares, increasing direct ownership by 39% to 660,500 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:27 PM ET
    $CG
    Investment Managers
    Finance

    Chief Financial Officer Redett John C. was granted 550,965 shares, increasing direct ownership by 50% to 1,651,081 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:18 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

    NASHUA, N.H., Jan. 6, 2026 /PRNewswire/ -- Resonetics® announced today that it has acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally, a medical technology design and development company focused on the neuromodulation market and based in Charleston, South Carolina. The acquisition strengthens Resonetics' Medical Power business by combining its comprehensive implantable battery technologies with advanced pulse generator manufacturing proc

    1/6/26 8:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

    MCLEAN, Va., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Meghan Harris, President and Chief Operations Officer (COO), to its board of directors. Harris brings over two decades of healthcare quality improvement, strategic operations, and client-focused innovation to the board. As President and COO, she oversees all public and commercial operations, solution development and quality, and contract implementations. "Meghan's appointment to the board reflects the significant impact of her strate

    12/17/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names Patty Obermaier as Chief Growth Officer

    MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced that former Microsoft executive Patty Obermaier has joined the company as Executive Vice President, Chief Growth Officer (CGO). In this role, Obermaier will lead the company's business development, marketing, and product management functions to bring innovative solutions to the healthcare industry's most pressing challenges. A distinguished executive with more than three decades of experience driving innovation, growth, and operational excellence across

    12/11/25 9:32:00 AM ET
    $ASGN
    $CG
    Professional Services
    Consumer Discretionary
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    ARMADA Acquires Poseidon Industrial LLC, Expanding Its Solutions Offering to the U.S. Navy and Defense Support Capabilities

    Strategic acquisition strengthens ARMADA's Fleet and enhances its ability to deliver preservation, modernization, and technical services across naval programs. ARMADA Parent Inc., a leading solutions provider for outsourced U.S. Navy ship repair and construction, today announced the acquisition of Poseidon Industrial LLC ("Poseidon"). Poseidon is a Virginia based company supporting the U.S. Navy and defense industry with mechanical, electrical, and systems integration services for modernization and repair projects. ARMADA, which is majority owned by Carlyle (NASDAQ:CG) and Stellex Capital Management, delivers integrated mission-critical solutions across its national footprint of operating

    11/12/25 1:00:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share

    NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its third quarter ended September 30, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "We continue to be active in the current market with disciplined underwriting standards. We experienced another quarter of net growth in the portfolio as we maintain leverage at the mid-point of our target range. On the other side of the balance sheet, we continued to optimize CGBD's capital structure post-quarter-end with our second institutional bond issuance and the repaymen

    11/4/25 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance